Vaxart, Inc.
VXRT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $28,700 | $7,379 | $107 | $892 |
| % Growth | 288.9% | 6,796.3% | -88% | – |
| Cost of Goods Sold | $0 | $4,500 | $0 | $48,749 |
| Gross Profit | $28,700 | $2,879 | $107 | -$47,857 |
| % Margin | 100% | 39% | 100% | -5,365.1% |
| R&D Expenses | $74,213 | $68,142 | $81,054 | $48,749 |
| G&A Expenses | $20,780 | $22,584 | $29,386 | $21,890 |
| SG&A Expenses | $20,780 | $22,584 | $29,386 | $21,890 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$4,500 | $4,254 | -$45,744 |
| Operating Expenses | $94,993 | $86,226 | $114,694 | $24,895 |
| Operating Income | -$66,293 | -$83,347 | -$114,587 | -$72,752 |
| % Margin | -231% | -1,129.5% | -107,090.7% | -8,156.1% |
| Other Income/Exp. Net | -$395 | $1,143 | $6,896 | $2,389 |
| Pre-Tax Income | -$66,688 | -$82,204 | -$107,691 | -$70,363 |
| Tax Expense | $260 | $261 | $67 | $107 |
| Net Income | -$66,948 | -$82,465 | -$107,758 | -$70,470 |
| % Margin | -233.3% | -1,117.6% | -100,708.4% | -7,900.2% |
| EPS | -0.14 | -0.17 | -0.22 | -0.14 |
| % Growth | 17.6% | 22.7% | -57.1% | – |
| EPS Diluted | -0.14 | -0.17 | -0.22 | -0.14 |
| Weighted Avg Shares Out | 487,263 | 487,263 | 487,263 | 487,263 |
| Weighted Avg Shares Out Dil | 487,263 | 487,263 | 487,263 | 487,263 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,543 | $2,652 | $1,247 | $81 |
| Interest Expense | $2,969 | $1,447 | $1,305 | $1,480 |
| Depreciation & Amortization | $8,850 | $8,624 | $5,805 | $2,432 |
| EBITDA | -$54,869 | -$72,133 | -$100,581 | -$66,451 |
| % Margin | -191.2% | -977.5% | -94,000.9% | -7,449.7% |